Our Technology
Molecularly Imprinted Polymers (MIPs) emerge as efficient biomimetic receptors with proven chemical stability and high specific recognition of target molecules. MIPs with characteristics such as easy preparation, low cost, scalability, and long shelf-life hold great promise to provide a new generation of chemical-biological sensors. MIPs offer the continuous and real-time detection of bacteria, viruses and biomolecules such as metabolites, hormones, proteins, nucleic acids, that can provide useful biological information for early-stage disease diagnosis, progression, remission of diseases, and patient monitoring.
In collaboration with a research lab at the University of Calgary, has developed a novel biosensing and point-of-care technology. This innovation addresses challenges of conventional metabolite sensing methods by leveraging molecularly imprinted polymers (MIP) for highly sensitive and specific detection. Validated using agmatine, the MIP biosensor incorporates electrodeposited Prussian blue nanoparticles to signal agmatine binding. The MXene@N-EEG nanocomposite stabilizes these nanoparticles, enabling a wide linear detection range (1.0 nM–100.0 μM, R2 = 0.9934) and a low detection limit (0.1 nM) in buffer and plasma samples. The microfluidic biosensor offers rapid response times (10 min incubation), low cost, and high reliability, making it promising for scalable point-of-care applications. Check our recent peer reviewed research articles
